Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Impact of alemtuzumab on health-related quality of life over 6 years in CARE-MS II trial extension patients with relapsing-remitting multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: May 31, 2019
Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trial.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: March 25, 2014
Showing 1-2 of 2
Last Updated: 09/26/2026